Skip to main content
Surgalign Holdings, Inc.
  • Login
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Choose a language for this website. English
    • English
    • Deutsch
    • English (EU)
  • Surgalign Holdings, Inc.
  • Digital Health
  • Products

    • Cervical Fixation
    • TL Fixation
    • Motion Preservation
    • Orthobiologics
    • Cervical IBF
    • TL IBF
    • SI Joint Fusion
    • Access / Instrumentation
    • View All Products
    PROCEDURES

    Surgalign offers the highest quality surgical solutions for all needs.

    View Procedures
  • Company

    • Executive Leadership
    • Board of Directors
    • Corporate Compliance
    • Company Credentials
    • Careers
    • Events
    • Contact Us
    • About Us
    About Us

    Learn how we are striving every day to deliver MORE THAN POSSIBLE.™

    Our Story
  • Contact Us

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
Dec 15, 2022 8:30am EST

Surgalign Announces 100th Case Completed Utilizing its Recently Launched Cortera™ Spinal Fixation System

View Press Release
Dec 13, 2022 12:00pm EST

Surgalign™ Expands Adoption of its HOLO Portal™ Surgical Guidance System in Virginia

View Press Release
Nov 16, 2022 4:05pm EST

Surgalign Announces Closing of $12.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

View Press Release
Nov 14, 2022 8:00am EST

Surgalign Announces $12.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

View Press Release
Nov 09, 2022 8:30am EST

Surgalign™ Announces Corporate Restructuring Program to Focus on Key Growth Areas

View Press Release
Nov 02, 2022 4:01pm EDT

Surgalign Announces Third Quarter 2022 Results and Provides Update on Business Operations and Financial Outlook

View Press Release
Oct 25, 2022 8:30am EDT

Surgalign Schedules Third Quarter 2022 Earnings Release for November 2, 2022

View Press Release
Oct 11, 2022 8:30am EDT

Surgalign™ Awarded 2022 Best New Technology Award from Orthopedics This Week for its HOLO Portal™ Surgical Guidance System

View Press Release
Oct 06, 2022 8:30am EDT

Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

View Press Release
Sep 26, 2022 8:30am EDT

Surgalign Launches Portfolio of Fortilink® with TiPlus™ Technology Products, Expanding its Addressable Market for Interbody Fusion Procedures

View Press Release
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • arrow_forward
rss_feed News RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
Surgalign Footer Logo.
Terms of Use Web Privacy Policy and Transparency Disclosure Notice
© 2023 Surgalign Spine Technologies, Inc. All rights reserved.

Market Data copyright © 2023 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.